The Biotechnology Industry Organization (BIO) will be holding its second annual IP & Diagnostics Symposium from 8:15 am to 2:30 pm on September 26, 2014 at the Hilton Alexandria Old Town Hotel in Alexandria, VA. The Symposium will review the current patent law landscape and evaluate the impact on both the genetic diagnostics and biopharmaceutical sectors. The program will review IP issues for diagnostics and companion diagnostics, and explore new collaborations and regulatory developments. In hosting the event, BIO aims to inform industry and government alike on how to move the science forward in the current climate. The Symposium will offer the following presentations and sessions:
• Session 1 -- Squaring the Circle: Obtaining Patents That Are Valid, Commercially Meaningful, and Enforceable -- Patent Docs author Donald Zuhn of McDonnell Boehnen Hulbert & Berghoff LLP will moderate a panel including June Cohan, Legal Advisor, Office of Patent Legal Administration, U.S. Patent & Trademark Office; Sherry Knowles, Knowles IP Strategies (former Senior Vice President and Chief Patent Counsel at GlaxoSmithKline); and Patent Docs author Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP (session sponsored by McDonnell Boehnen Hulbert & Berghoff LLP).
• Session 2 -- Recent Patent Litigation & Disputes -- Jennifer L. Fox of Brinks Hofer Gilson & Lione will moderate a panel including Andrew Shyjan, Corporate Counsel of MedImmune.
• Session 3 -- Is there a New Frontier in University/Industry and Industry/Industry Collaborations? -- Warren Woessner of Schwegman, Lundberg & Woessner, P.A. will moderate a panel including Leslie Fischer, Sr. Patent Attorney at Novartis Pharmaceuticals Corp.; Rodney Sparks, Sr. Biotechnology Patent Counsel for the University of Virginia Licensing & Ventures Group; and David Hoffman, Sr. Corporate Counsel, IP & Transactions, Genomic Health, Inc.
Session 4 (Working Luncheon) -- Potential Impacts of Regulatory Changes -- Phoebe Mounts of Morgan, Lewis & Bockius, LLP will moderate a panel including Scott McGoohan, Vice President, Reimbursement & Scientific Affairs, American Clinical Laboratory Association; and Alberto Gutierrez, Director of the Office of In Vitro Diagnostics and Radiological Health, Food & Drug Administration.
An agenda for the Symposium, including a list of speakers, moderators, and panelists can be obtained here.
Although there is no registration fee for the Symposium, space is limited and attendees must register for the program. A registration form can be obtained here.